Vitamin D deficiency is associated with increased risks of mortality in people with chronic kidney disease. The benefits and harm of vitamin D supplementation on cardiovascular outcomes and mortality are unknown. We aimed to assess the effectiveness of calcifediol in reducing mortality in patients with vitamin D insufficiency on hemodialysis compared to no additional therapy.
Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial
Russo, Domenico;Gesualdo, Loreto;Santoro, Antonio;
2021-01-01
Abstract
Vitamin D deficiency is associated with increased risks of mortality in people with chronic kidney disease. The benefits and harm of vitamin D supplementation on cardiovascular outcomes and mortality are unknown. We aimed to assess the effectiveness of calcifediol in reducing mortality in patients with vitamin D insufficiency on hemodialysis compared to no additional therapy.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s40620-021-01104-z.pdf
non disponibili
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
